agilon health (NYSE:AGL – Free Report) had its price objective upped by Truist Financial from $6.40 to $6.50 in a research note released on Friday, Benzinga reports. The brokerage currently has a hold rating on the stock.
Several other equities analysts have also recently commented on AGL. Barclays began coverage on shares of agilon health in a research report on Wednesday, March 6th. They issued an underweight rating and a $5.00 target price for the company. Evercore ISI lowered their price objective on shares of agilon health from $7.00 to $6.00 and set an in-line rating for the company in a research report on Wednesday, February 28th. Jefferies Financial Group reiterated a hold rating and set a $6.50 price objective (down from $25.00) on shares of agilon health in a research report on Monday, February 26th. Stifel Nicolaus lowered their price objective on shares of agilon health from $8.00 to $7.00 and set a hold rating for the company in a research report on Wednesday, May 1st. Finally, Benchmark lowered their price objective on shares of agilon health from $13.00 to $9.00 and set a buy rating for the company in a research report on Thursday, February 29th. One equities research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of Hold and a consensus target price of $9.25.
View Our Latest Report on agilon health
agilon health Trading Up 7.9 %
Shares of NYSE AGL traded up $0.44 during midday trading on Friday, reaching $6.10. 3,674,281 shares of the stock were exchanged, compared to its average volume of 5,389,874. The business has a 50-day simple moving average of $5.26 and a two-hundred day simple moving average of $7.74. The company has a market capitalization of $2.51 billion, a price-to-earnings ratio of -8.71 and a beta of 0.52. agilon health has a 12 month low of $4.41 and a 12 month high of $21.52. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.33 and a quick ratio of 1.33.
agilon health (NYSE:AGL – Get Free Report) last released its quarterly earnings data on Tuesday, February 27th. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.28) by ($0.13). The firm had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.02 billion. agilon health had a negative return on equity of 26.15% and a negative net margin of 5.67%. The firm’s revenue for the quarter was up 71.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.14) earnings per share. As a group, equities research analysts expect that agilon health will post -0.35 EPS for the current year.
Hedge Funds Weigh In On agilon health
Hedge funds and other institutional investors have recently modified their holdings of the company. Signaturefd LLC grew its position in agilon health by 73.7% during the third quarter. Signaturefd LLC now owns 1,673 shares of the company’s stock valued at $30,000 after buying an additional 710 shares during the period. Quest Partners LLC bought a new position in agilon health during the fourth quarter valued at $45,000. Neo Ivy Capital Management bought a new position in agilon health during the fourth quarter valued at $47,000. Van ECK Associates Corp raised its stake in shares of agilon health by 164.7% in the third quarter. Van ECK Associates Corp now owns 4,111 shares of the company’s stock valued at $73,000 after acquiring an additional 2,558 shares during the period. Finally, Covestor Ltd raised its stake in shares of agilon health by 1,439.6% in the third quarter. Covestor Ltd now owns 5,912 shares of the company’s stock valued at $105,000 after acquiring an additional 5,528 shares during the period.
About agilon health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles
Before you consider agilon health, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and agilon health wasn’t on the list.
While agilon health currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
MarketBeat’s analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Source: marketbeat.com
